141 related articles for article (PubMed ID: 34848473)
1. A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response.
Nomura T; Kurebayashi J; Moriya T; Saito W; Murata T; Yamamoto J; Hozumi C; Hoffman RM
Anticancer Res; 2021 Dec; 41(12):6191-6197. PubMed ID: 34848473
[TBL] [Abstract][Full Text] [Related]
2. A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib.
Yamamoto J; Murata T; Tashiro Y; Higuchi T; Sugisawa N; Nishino H; Inubushi S; Sun YU; Lim H; Miyake K; Hongo A; Nomura T; Saitoh W; Moriya T; Tanino H; Hozumi C; Bouvet M; Singh SR; Endo I; Hoffman RM
Anticancer Res; 2020 May; 40(5):2509-2514. PubMed ID: 32366395
[TBL] [Abstract][Full Text] [Related]
3. Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model.
Yamamoto J; Murata T; Sugisawa N; Higuchi T; Tashiro Y; Nishino H; Inubushi S; Sun YU; Lim H; Miyake K; Shimoya K; Nomura T; Kurebayashi J; Tanino H; Hozumi C; Bouvet M; Singh SR; Endo I; Hoffman RM
Anticancer Res; 2020 May; 40(5):2475-2479. PubMed ID: 32366391
[TBL] [Abstract][Full Text] [Related]
4.
Hamada K; Aoki Y; Yamamoto J; Hozumi C; Zhao M; Murata T; Sugisawa N; Bouvet M; Tsunoda T; Hoffman RM
In Vivo; 2021; 35(6):3067-3071. PubMed ID: 34697138
[TBL] [Abstract][Full Text] [Related]
5. A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model.
Lim HI; Yamamoto J; Inubushi S; Nishino H; Tashiro Y; Sugisawa N; Han Q; Sun YU; Choi HJ; Nam SJ; Kim MB; Lee JS; Hozumi C; Bouvet M; Singh SR; Hoffman RM
Anticancer Res; 2020 May; 40(5):2481-2485. PubMed ID: 32366392
[TBL] [Abstract][Full Text] [Related]
6. Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
Murakami T; Murata T; Kawaguchi K; Kiyuna T; Igarashi K; Hwang HK; Hiroshima Y; Hozumi C; Komatsu S; Kikuchi T; Lwin TM; Delong JC; Miyake K; Zhang Y; Tanaka K; Bouvet M; Endo I; Hoffman RM
Anticancer Res; 2017 Jan; 37(1):61-65. PubMed ID: 28011474
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Oral Recombinant Methioninase and Eribulin on a PDOX Model of Triple-negative Breast Cancer (TNBC) Liver Metastasis.
Lim HI; Sun YU; Han Q; Yamamoto J; Hoffman RM
In Vivo; 2021; 35(5):2531-2534. PubMed ID: 34410939
[TBL] [Abstract][Full Text] [Related]
8. Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model.
Lim HI; Yamamoto J; Han Q; Sun YU; Nishino H; Tashiro Y; Sugisawa N; Tan Y; Choi HJ; Nam SJ; Bouvet M; Hoffman RM
In Vivo; 2020; 34(6):3163-3169. PubMed ID: 33144420
[TBL] [Abstract][Full Text] [Related]
9. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
[TBL] [Abstract][Full Text] [Related]
10. Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Miyake K; Murakami T; Kiyuna T; Igarashi K; Kawaguchi K; Li Y; Singh AS; Dry SM; Eckardt MA; Hiroshima Y; Momiyama M; Matsuyama R; Chishima T; Endo I; Eilber FC; Hoffman RM
J Cell Biochem; 2018 Jan; 119(1):967-972. PubMed ID: 28681998
[TBL] [Abstract][Full Text] [Related]
11. Osteosarcoma of the Breast in a Patient Derived Orthotopic Xenograft (PDOX) Mouse Model Is Arrested by both Cisplatinum and Eribulin.
Masaki N; Wu NF; Aoki Y; Yamamoto J; Miyazaki J; Hoffman RM
In Vivo; 2021; 35(6):3107-3110. PubMed ID: 34697141
[TBL] [Abstract][Full Text] [Related]
12. Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Razmara AM; Sollier E; Kisirkoi GN; Baker SW; Bellon MB; McMillan A; Lemaire CA; Ramani VC; Jeffrey SS; Casey KM
Clin Exp Metastasis; 2020 Jun; 37(3):413-424. PubMed ID: 32335861
[TBL] [Abstract][Full Text] [Related]
13. Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Sugisawa N; Higuchi T; Han Q; Hozumi C; Yamamoto J; Tashiro Y; Nishino H; Kawaguchi K; Bouvet M; Murata T; Unno M; Hoffman RM
Cancer Chemother Pharmacol; 2021 Jul; 88(1):61-67. PubMed ID: 33768300
[TBL] [Abstract][Full Text] [Related]
14. Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study.
Arpino G; De Placido S; De Angelis C
Anticancer Drugs; 2015 Jan; 26(1):117-22. PubMed ID: 25115342
[TBL] [Abstract][Full Text] [Related]
15. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
[TBL] [Abstract][Full Text] [Related]
16. [A Patient with a Pathological Complete Response to Neo-Adjuvant Chemotherapy for Triple-Negative Breast Cancer Followed by Recurrence after Six Months].
Hayashi K; Waraya M; Habiro T; Hosoya S; Sengoku N; Tanino H; Hayakawa K; Inukai M; Saegusa M; Watanabe M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2050-2053. PubMed ID: 28133218
[TBL] [Abstract][Full Text] [Related]
17. [A Case of Triple Negative Breast Cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract][Full Text] [Related]
18. Eribulin Suppressed Cisplatinum- and Doxorubicin-resistant Recurrent Lung Metastatic Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
Kiyuna T; Tome Y; Miyake K; Murakami T; Oshiro H; Igarashi K; Kawaguchi K; Hsu J; Singh M; Li Y; Nelson S; Bouvet M; Singh SR; Kanaya F; Hoffman RM
Anticancer Res; 2019 Sep; 39(9):4775-4779. PubMed ID: 31519578
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.
Hiroshima Y; Zhang Y; Zhang N; Maawy A; Mii S; Yamamoto M; Uehara F; Miwa S; Yano S; Murakami T; Momiyama M; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Murata T; Endo I; Hoffman RM
PLoS One; 2015; 10(2):e0117417. PubMed ID: 25689852
[TBL] [Abstract][Full Text] [Related]
20. Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer.
Lim HI; Hamada K; Yamamoto J; Han Q; Tan Y; Choi HJ; Nam SJ; Bouvet M; Hoffman RM
In Vivo; 2020; 34(5):2281-2286. PubMed ID: 32871751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
